Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.

Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA.

Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13028-33. Epub 2006 Aug 21.

2.

Structural basis for the regulation of insulin-like growth factors by IGF binding proteins.

Siwanowicz I, Popowicz GM, Wisniewska M, Huber R, Kuenkele KP, Lang K, Engh RA, Holak TA.

Structure. 2005 Jan;13(1):155-67.

3.

Partial IGF affinity of circulating N- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain.

Ständker L, Braulke T, Mark S, Mostafavi H, Meyer M, Höning S, Giménez-Gallego G, Forssmann WG.

Biochemistry. 2000 May 2;39(17):5082-8.

PMID:
10819974
4.

Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.

Kuang Z, Yao S, McNeil KA, Thompson JA, Bach LA, Forbes BE, Wallace JC, Norton RS.

Biochemistry. 2007 Dec 4;46(48):13720-32. Epub 2007 Nov 7.

PMID:
17985932
5.

The N-terminal subdomain of insulin-like growth factor (IGF) binding protein 6. Structure and interaction with IGFs.

Chandrashekaran IR, Yao S, Wang CC, Bansal PS, Alewood PF, Forbes BE, Wallace JC, Bach LA, Norton RS.

Biochemistry. 2007 Mar 20;46(11):3065-74. Epub 2007 Feb 17.

PMID:
17305365
6.

Structure-function analysis of the human insulin-like growth factor binding protein-4.

Qin X, Strong DD, Baylink DJ, Mohan S.

J Biol Chem. 1998 Sep 4;273(36):23509-16.

7.

Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6.

Bach LA, Hsieh S, Sakano K, Fujiwara H, Perdue JF, Rechler MM.

J Biol Chem. 1993 May 5;268(13):9246-54.

8.

Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation.

Yan X, Forbes BE, McNeil KA, Baxter RC, Firth SM.

J Biol Chem. 2004 Dec 17;279(51):53232-40. Epub 2004 Oct 12.

11.

Insulin-like growth factor binding protein-2: contributions of the C-terminal domain to insulin-like growth factor-1 binding.

Kibbey MM, Jameson MJ, Eaton EM, Rosenzweig SA.

Mol Pharmacol. 2006 Mar;69(3):833-45. Epub 2005 Nov 23.

12.

Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.

Mark S, Kübler B, Höning S, Oesterreicher S, John H, Braulke T, Forssmann WG, Ständker L.

Biochemistry. 2005 Mar 8;44(9):3644-52.

PMID:
15736974
15.

[The structural organization of binding determinants in insulin-like growth factor-I (IGF-I) molecule].

Kolychev AP.

Zh Evol Biokhim Fiziol. 2010 Jan-Feb;46(1):74-94. Review. Russian.

PMID:
20297673
16.

Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.

Headey SJ, Leeding KS, Norton RS, Bach LA.

J Mol Endocrinol. 2004 Oct;33(2):377-86.

PMID:
15525596
17.
18.

Structure and properties of the C-terminal domain of insulin-like growth factor-binding protein-1 isolated from human amniotic fluid.

Sala A, Capaldi S, Campagnoli M, Faggion B, Labò S, Perduca M, Romano A, Carrizo ME, Valli M, Visai L, Minchiotti L, Galliano M, Monaco HL.

J Biol Chem. 2005 Aug 19;280(33):29812-9. Epub 2005 Jun 22.

20.

Supplemental Content

Support Center